{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:27:20Z","timestamp":1789954040249,"version":"4.0.1"},"reference-count":44,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            A derivative of the TEM-1 \u03b2-lactamase producing clinically significant levels of resistance to ceftazidime and \u03b2-lactamase inhibitors in the presence of penicillins was generated following five rounds of DNA shuffling and selection. This complex mutant enzyme contained three amino acid substitutions including those of residues 104 and 276 that are known to produce extended-spectrum resistance and, correspondingly, resistance to \u03b2-lactamase inhibitors. Although the Glu104Lys substitution by itself produced low levels of ceftazidime resistance, additional amino acid replacements in the enzyme with the triple mutation resulted in further enhancement of resistance to ceftazidime. Kinetic studies of the purified \u03b2-lactamase enzyme with the triple mutation indicated enhancement of the catalytic efficiency for turnover (\n            <jats:italic>k<\/jats:italic>\n            <jats:sub>cat<\/jats:sub>\n            \/\n            <jats:italic>\n              K\n              <jats:sub>m<\/jats:sub>\n            <\/jats:italic>\n            ) of ceftazidime. The increases in the\n            <jats:italic>\n              K\n              <jats:sub>i<\/jats:sub>\n            <\/jats:italic>\n            values of both clavulanic acid and tazobactam for the enzyme with the triple mutation were consistent with the observed bacterial resistance to the reversibility of \u03b2-lactam resistance with these inhibitors.\n          <\/jats:p>","DOI":"10.1128\/aac.46.3.646-653.2002","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:56:57Z","timestamp":1027763817000},"page":"646-653","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["Mutant TEM \u03b2-Lactamase Producing Resistance to Ceftazidime, Ampicillins, and \u03b2-Lactamase Inhibitors"],"prefix":"10.1128","volume":"46","author":[{"given":"Sergei","family":"Vakulenko","sequence":"first","affiliation":[{"name":"Departments of Biochemistry and Molecular Biology"},{"name":"Medicine, Wayne State University, Detroit, Michigan 48201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasantila","family":"Golemi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Wayne State University, Detroit, Michigan 48202"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","first-page":"75","volume":"120","year":"1994","unstructured":"Belaaouaj, A., C. Lapoumeroulie, M. M. Canica, G. Vedel, P. Nevot, R. Krishnamoorthy, and G. Paul. 1994. Nucleotide sequences of the genes coding for the TEM-like \u03b2-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol. Lett.120:75-80.","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.10.2059"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0167-4838(94)00188-M","volume":"1247","year":"1995","unstructured":"Bonomo, R. A., C. G. Dawes, J. R. Knox, and D. M. Shlaes. 1995. \u03b2-Lactamase mutations far from the active site influence inhibitor binding. Biochim. Biophys. Acta1247:121-125.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.9.1940"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.11.2547"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/38.2.183"},{"key":"e_1_3_1_8_2","first-page":"111","volume":"120","year":"1994","unstructured":"Brun, T., J. Peduzzi, M. M. Canica, G. Paul, P. Nevot, M. Barthelemy, and R. Labia. 1994. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to \u03b2-lactamase inhibitors. FEMS Microbiol. Lett.120:111-117.","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.6.1211"},{"key":"e_1_3_1_10_2","first-page":"71","year":"1998","unstructured":"Bush, K., and S. Mobashery. 1998. How \u03b2-lactamases have driven pharmaceutical drug discovery: from mechanistic knowledge to clinical circumvention, p. 71-98. In B. P. Rosen and S. Mobashery (ed.), Resolving the antibiotic paradox. Progress in understanding drug resistance and development of new antibiotics. Plenum Press, New York, N.Y.","journal-title":"Resolving the antibiotic paradox"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.2.374"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2452"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/38.1.127"},{"key":"e_1_3_1_14_2","unstructured":"Cornish-Bowden A. 1995. Fundemantals of enzyme kinetics p. 44-47. Portland Press Ltd. London United Kingdom."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)36729-8"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj0550170"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1499-1505.2000"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1139\/o78-166","volume":"56","year":"1978","unstructured":"Glick, B. R., L. J. Brubacher, and D. J. Legget. 1978. A graphical method for extracting rate constants from some enzyme-catalyzed reactions not monitored to completion. Can. J. Biochem.56:1055-1057.","journal-title":"Can. J. Biochem."},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.2.427"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.5.707"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/44.3.309"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1006\/jmbi.1996.0279","volume":"258","year":"1996","unstructured":"Huang, W. Z., J. Petrosino, M. Hirsch, P. S. Shenkin, and T. Palzkill. 1996. Amino acid sequence determinants of \u03b2-lactamase structure and activity. J. Mol. Biol.258:688-703.","journal-title":"J. Mol. Biol."},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.5.1134"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.12.2593"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0003-2697(87)90203-X","volume":"165","year":"1987","unstructured":"Koerber, S. C., and A. L. Fink. 1987. The analysis of enzyme progress curves by numerical differentiation, including competitive product inhibition and enzyme reactivation. Anal. Biochem.165:75-87.","journal-title":"Anal. Biochem."},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2580"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1994.tb01011.x"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3050033"},{"key":"e_1_3_1_29_2","first-page":"517","volume":"13","year":"1994","unstructured":"Philippon, A., G. Arlet, and P. H. Lagrange. 1994. Origin and impact of plasmid-mediated extended-spectrum \u03b2-lactamases. Eur. J. Clin. Microbiol. Infect. Dis.13:517-529.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.4.838"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","unstructured":"Quinn J. P. 1994. Clinical significance of extended-spectrum \u03b2-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 13 (Suppl. 1) : 39-42.","DOI":"10.1007\/BF02390683"},{"key":"e_1_3_1_32_2","unstructured":"Sambrook J. E. F. Fritsch and T. Maniatis. 1989. Molecular cloning: a laboratory manual 2nd ed. Cold Spring Harbor Laboratory Press Cold Spring Harbor N.Y."},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.31.18240"},{"key":"e_1_3_1_34_2","unstructured":"Silverman R. 1988. Mechanism-based enzyme inactivation: chemistry and enzymology vol. 1. CRC Press Inc. Boca Raton Fla."},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/36.suppl_A.19"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.6.1322"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.11.2478"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.8.1881"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.22.10747"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/370389a0"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi990758z"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.7.1542"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.33.23052"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1073\/pnas.98.3.903","volume":"98","year":"2001","unstructured":"Yano, T., and H. Kagamiyama. 2001. Directed evolution of ampicillin-resistant activity from a functionally unrelated DNA fragment: a laboratory model of molecular evolution. Proc. Natl. Acad. Sci. USA98:903-907.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.5.1085"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.3.646-653.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.3.646-653.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T17:43:09Z","timestamp":1645465389000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.46.3.646-653.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1128\/AAC.46.3.646-653.2002"],"URL":"https:\/\/doi.org\/10.1128\/aac.46.3.646-653.2002","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]},"assertion":[{"value":"2001-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-11-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}